<DOC>
	<DOC>NCT02384538</DOC>
	<brief_summary>This is a multicenter, randomized, double-blind, placebo-controlled study to compare the safety and efficacy of ABT-981 to placebo in subjects with erosive hand osteoarthritis.</brief_summary>
	<brief_title>A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>1. Male or female between the ages of 35 to 80. 2. Must fulfill 1990 American College of Rheumatology (ACR) hand osteoarthritis (OA) criteria 3. Must have radiographic evidence of erosive hand OA 4. Have one or more clinical signs and symptoms of active inflammation in at least three hand joints 5. Subject Assessment of Hand Pain Intensity in at least one hand is â‰¥ 6. 1. Previous exposure to any antiinterleukin1 treatment, to corticosteroids within 1 month prior to Screening, to intraarticular hyaluronic acid injection into hand joint(s) within 6 months prior to Screening, to any immunosuppressive biologic therapy within 1 month or 5 halflives (whichever is longer) prior to the first dose of study drug, OR current use of immunosuppressive oral medications within 3 months or 5 halflives (whichever is longer) prior to the first dose of study drug. 2. Absolute neutrophil count &lt; 2,000 mm3 3. Diagnosis of one or more of the following: Fibromyalgia, Inflammatory arthritis such as rheumatoid arthritis, peripheral seronegative spondyloarthropathy, Psoriatic arthritis, psoriasis, Microcrystalline (including gout and pseudo gout) arthritis affecting the hands, Any OA of the hands due to an infectious origin or acute traumatic episode, secondary OA or OA linked to cartilage and bone dysplasia, Other chronic painful syndromes that could interfere with assessment of pain at the hand(s). 4. Any uncontrolled medical illness or an unstable treatment or therapy. 5. Clinically significant cardiac disease. 6. Evidence of dysplasia or history of malignancy other than a successfully treated nonmetastatic cutaneous squamous cell or basal cell carcinoma or localized carcinoma in situ of the cervix. 7. History of persistent chronic or active infection(s) requiring hospitalization or treatment with antimicrobials/antibiotics. 8. Any reason that prohibits a subject to undergo an MRI.</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Arthritis</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Joint diseases</keyword>
	<keyword>Osteoarthritis, Hand</keyword>
	<keyword>Musculoskeletal diseases</keyword>
	<keyword>Rheumatic diseases</keyword>
</DOC>